Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Head & Neck 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 12Peritoneal Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 7Colorectal Neoplasms 7Fallopian Tube Neoplasms 5Endometrial Neoplasms 5Triple Negative Breast Neoplasms 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Neoplasms 3Melanoma 3Esophageal Neoplasms 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Pseudomyxoma Peritonei 2Pancreatic Neoplasms 2Lung Neoplasms 2Gestational Trophoblastic Disease 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Appendiceal Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Teratoma, Ovarian 1Somatostatinoma 1

Interventions

Carboplatin 2130-nm albumin-bound paclitaxel 2tremelimumab 1durvalumab 1cc-486 1amatuximab 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1EC regimen 1Cisplatin 1CP protocol 1Azacitidine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Leucovorin × Gynecologic × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡